- Advertisement -

Related

Brexit illustrates diversification benefits of CTAs Lyxor claims

- Advertisement -

Stockholm (HedgeNordic) – The strong returns and decorrelated performance characteristics of CTAs post Brexit show the diversification benefits of trend following strategies, according to a recent expert opinion from Lyxor’s Guillaume Jamet, principal portfolio manager of the Lyxor Epsilon Programme.

Jamet says that the environment for trend following strategies has been mixed in the second quarter which is illustrated by the SG Trend Index returning -1.2 % during the period. The reason for the non-performance is that only one of two conditions for strong trend following returns have been met, according to the manager.

In order for trend followers to strive, the strategy, according to Jamet, needs market trendiness to be high and market correlations to stay low. Recently, the trendiness has been weak, while correlations have been low. However, correlations spiked following the  Brexit turmoil.

Jamet says there is no evidence that we have entered a high correlation regime (which would be negative for trend following), instead he highlights the improved trendiness imposed by Brexit.

“The last few months featured several clear market trends, which all seemed to anticipate a Brexit, including; depreciation of the British pound, appreciation of the Japanese yen, (which typically serves as a safe haven for Asian investors) and a rally in both Gilts and Bunds, as a result of flight to quality and in anticipation of even more accommodative monetary policies”, Jamet says continuing:

“In the months before the referendum, markets were pricing in a Brexit. In contrast with many discretionary managers, CTAs did not overreact to the reversal in market sentiment which occurred the week before the actual vote, and held on to their long Brexit positions. This illustrates the advantage of a strategy which analyses markets differently.”

 

Picture: (c) Nata-Lia—shutterstock.com

 

 

 

 

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Jonathan Furelid
Jonathan Furelid
Jonathan Furelid is editor and hedge fund analyst at HedgeNordic. Having a background allocating institutional portfolios of systematic strategies at CTA-specialist RPM Risk & Portfolio Management, Mr. Furelid’s focus areas include sytematic macro and CTAs. Jonathan can be reached at: jonathan@hedgenordic.com

Latest Articles

More Unknowns, More Dispersion in Private Equity

Private credit managers with exposure to software companies recently faced investor withdrawals as concerns mounted over how artificial intelligence could disrupt parts of the...

Private Equity No Longer Optional as Value Creation Moves Behind Closed Doors

As businesses stay private for longer, an increasing share of value creation now happens away from public exchanges, forcing investors to rethink where they...

A Decade of Thematic Private Equity: Summa Equity Sees Stronger Tailwinds Than Ever

While parts of the private equity industry have faced a challenging dealmaking environment in recent years, Nordic mid-market buyout manager Summa Equity has navigated...

Direct Lending Goes Through First Proper Credit Cycle 

After years of explosive growth and strong returns, private credit is facing its first meaningful stress test, particularly within direct lending, which has become...

Beyond Traditional Fixed Income: Why Aegon AM Sees Opportunity Across ABS and CLO Markets

Every day, households borrow money to buy homes, finance cars, pay for education, or fund everyday consumption. These mortgages, auto loans, consumer loans, and...

Financing the Energy Buildout: The Growing Role of Infrastructure Credit

Infrastructure has traditionally been viewed as one of the more defensive corners of private markets, characterized by essential services, stable cash flows, and hard-asset...

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -